Genentech - Another Home Run

I just saw the news this morning that the Avastin appeared effective against breast cancer. Genentech is up +8 to around 66 in pre market open. Analyst are now projecting ~ 4$ billion in annual Avastin sales. This is huge not only for the Genentech, but for the biotech sector as well.